Product Information
BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB is a generic product labeled by Advagen Pharma Ltd., priced at $0.2430 per EA under NDC 72888022001. Its NADAC has been published 26 times since Feb 25, 2026.
FDA first approved this application on May 19, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB
benazepril hydrochloride and hydrochlorothiazideStrength
10; 12.5 mg/1; mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888022001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020033FDA Approved
5/19/1992
TE Code
AB
On Market Since
12/5/2024
Pharmacological Classes
Price Statistics
The NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has been published 26 times since Feb 25, 2026, and over the history we have for it it has risen 6.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2430 per EA |
|---|---|
| All-time high | $0.2521 (Jul 15, 2026) |
| All-time low | $0.2239 (Apr 22, 2026) |
| 52-week high | $0.2521 |
| 52-week low | $0.2239 |
| Median price | $0.2432 |
| Average price | $0.2381 |
| Largest weekly change | +8.7% (May 20, 2026) |
| Weeks tracked | 26 |
| Tracking since | Feb 25, 2026 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the benazepril hydrochloride and hydrochlorothiazide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB, manufactured by Advagen Pharma Ltd., is $0.2430 per EA (NDC 72888022001), effective Aug 19, 2026.
How has the price of BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has risen 6.5%. It has been tracked across 26 weekly CMS publications since Feb 25, 2026.
What are the highest and lowest recorded NADAC prices for BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?
Since Feb 25, 2026, the NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has ranged from a low of $0.2239 (Apr 22, 2026) to a high of $0.2521 (Jul 15, 2026), with a median of $0.2432 per EA.
Are there cheaper alternatives to BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?
BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB (NDC 72888022001) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.